➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Baxter
Harvard Business School
McKesson
Colorcon

Last Updated: June 7, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIFLUNISAL

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Diflunisal

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00294671 The Effect of Diflunisal on Familial Amyloidosis Completed Food and Drug Administration (FDA) Phase 2/Phase 3 2006-02-01 The purpose of this study is to determine if diflunisal can prevent progressive lower leg nerve damage in patients with familial amyloidosis polyneuropathy. Funding Source - FDA OOPD; NINDS
NCT00294671 The Effect of Diflunisal on Familial Amyloidosis Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 2/Phase 3 2006-02-01 The purpose of this study is to determine if diflunisal can prevent progressive lower leg nerve damage in patients with familial amyloidosis polyneuropathy. Funding Source - FDA OOPD; NINDS
NCT00294671 The Effect of Diflunisal on Familial Amyloidosis Completed Boston University Phase 2/Phase 3 2006-02-01 The purpose of this study is to determine if diflunisal can prevent progressive lower leg nerve damage in patients with familial amyloidosis polyneuropathy. Funding Source - FDA OOPD; NINDS
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Diflunisal

Condition Name

Condition Name for Diflunisal
Intervention Trials
Bipolar Disorder 1
Atrial Fibrillation 1
HIV Infection 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Diflunisal
Intervention Trials
Amyloid Neuropathies, Familial 2
Amyloidosis 2
Bipolar Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Diflunisal

Trials by Country

Trials by Country for Diflunisal
Location Trials
United States 5
United Kingdom 2
Sweden 2
Italy 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Diflunisal
Location Trials
Kansas 1
Texas 1
New York 1
Minnesota 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Diflunisal

Clinical Trial Phase

Clinical Trial Phase for Diflunisal
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Diflunisal
Clinical Trial Phase Trials
Completed 4
Suspended 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Diflunisal

Sponsor Name

Sponsor Name for Diflunisal
Sponsor Trials
National Institute of Neurological Disorders and Stroke (NINDS) 1
University of British Columbia 1
Food and Drug Administration (FDA) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Diflunisal
Sponsor Trials
Other 10
U.S. Fed 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Baxter
Boehringer Ingelheim
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.